Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
835.24
786.52
816.79
917.49
836.29
1,116.86
1,115.53
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
835.24
786.52
816.79
917.49
836.29
1,116.86
1,115.53
Raw Material Cost
314.33
292.19
289.61
321.00
305.70
305.12
302.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.11
33.29
46.19
49.37
55.08
18.42
13.98
Selling and Distribution Expenses
411.32
423.81
503.08
566.43
657.43
800.78
730.84
Other Expenses
2.82
0.58
-0.29
-0.52
0.23
1.82
2.85
Total Expenditure (Excl Depreciation)
770.92
755.11
836.00
931.55
1,020.48
1,142.50
1,075.31
Operating Profit (PBDIT) excl Other Income
64.3
31.400000000000002
-19.2
-14.1
-184.20000000000002
-25.6
40.199999999999996
Other Income
38.35
44.64
33.44
35.53
31.49
56.79
34.45
Operating Profit (PBDIT)
160.28
131.64
73.33
72.06
-102.30
80.66
131.57
Interest
17.11
33.29
46.19
49.37
55.08
18.42
13.98
Exceptional Items
-4.26
-4.58
-48.20
-31.54
-74.85
-22.94
-42.63
Gross Profit (PBDT)
520.92
494.33
527.18
596.49
530.59
811.74
813.53
Depreciation
59.27
59.38
65.53
64.72
65.68
53.24
57.32
Profit Before Tax
79.63
34.40
-86.59
-73.57
-297.92
-13.93
17.64
Tax
5.88
6.55
7.90
9.07
-17.82
3.67
5.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.19
25.20
-118.52
-91.44
-262.37
5.30
7.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.19
25.20
-118.52
-91.44
-262.37
5.30
7.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
32.57
23.53
20.60
16.89
-18.20
-7.07
2.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
74.76
48.73
-97.92
-74.55
-280.57
-1.78
9.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
343.00
600.13
574.94
589.41
687.10
815.89
814.75
Earnings per share (EPS)
0.17
0.1
-0.5
-0.4
-1.23
0.03
0.03
Diluted Earnings per share
0.17
0.1
-0.5
-0.4
-1.23
0.03
0.03
Operating Profit Margin (Excl OI)
7.5%
3.51%
-3.14%
-3.07%
-23.85%
-2.63%
3.57%
Gross Profit Margin
16.63%
11.92%
-2.58%
-0.96%
-27.77%
3.52%
6.72%
PAT Margin
5.05%
3.2%
-14.51%
-9.97%
-31.37%
0.47%
0.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 6.19% vs -3.71% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 53.59% vs 149.74% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 40.11% vs 118.05% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -48.65% vs -27.92% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shanxi C&Y Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
835.24
0
835.24
Other Operating Income
0.00
0.00
0.00
Total Operating income
835.24
0
835.24
Raw Material Cost
314.33
0
314.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.11
0
17.11
Selling and Distribution Expenses
411.32
0
411.32
Other Expenses
2.82
0.00
2.82
Total Expenditure (Excl Depreciation)
770.92
0
770.92
Operating Profit (PBDIT) excl Other Income
64.33
0.00
64.33
Other Income
38.35
0
38.35
Operating Profit (PBDIT)
160.28
0
160.28
Interest
17.11
0
17.11
Exceptional Items
-4.26
0
-4.26
Gross Profit (PBDT)
520.92
0
520.92
Depreciation
59.27
0
59.27
Profit Before Tax
79.63
0
79.63
Tax
5.88
0
5.88
Provisions and contingencies
0
0
0.00
Profit After Tax
42.19
0
42.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.19
0
42.19
Share in Profit of Associates
0
0
0.00
Minority Interest
32.57
0
32.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
74.76
0
74.76
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
343.00
0
343.00
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
7.50%
0%
0.00
7.50%
Gross Profit Margin
16.63%
0%
0.00
16.63%
PAT Margin
5.05%
0%
0.00
5.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 83.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 6.19% vs -3.71% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 7.48 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 53.59% vs 149.74% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.11% vs 118.05% in Dec 2023
Annual - Interest
Interest 1.71 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -48.65% vs -27.92% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.50%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
